95 related articles for article (PubMed ID: 10592922)
1. Can dopamine prevent the renal side effects of indomethacin? A prospective randomized clinical study.
Baenziger O; Waldvogel K; Ghelfi D; Arbenz U; Fanconi S
Klin Padiatr; 1999; 211(6):438-41. PubMed ID: 10592922
[TBL] [Abstract][Full Text] [Related]
2. Oral ibuprofen and indomethacin for treatment of patent ductus arteriosus in premature infants: a randomized trial at Ramathibodi Hospital.
Supapannachart S; Limrungsikul A; Khowsathit P
J Med Assoc Thai; 2002 Nov; 85 Suppl 4():S1252-8. PubMed ID: 12549803
[TBL] [Abstract][Full Text] [Related]
3. Furosemide does not prevent indomethacin-induced renal side effects in preterm infants.
Romagnoli C; Zecca E; Papacci P; De Carolis MP; Giannini R; Gallini F; Tortorolo G
Clin Pharmacol Ther; 1997 Aug; 62(2):181-6. PubMed ID: 9284854
[TBL] [Abstract][Full Text] [Related]
4. Is oral indomethacin effective in treatment of preterm infants with patent ductus arteriosus?
Satar M; Yapicioğlu H; Narli N; Ozbarlas N; Küçükosmanoğlu O; Tutak E
Turk J Pediatr; 2004; 46(2):137-41. PubMed ID: 15214742
[TBL] [Abstract][Full Text] [Related]
5. A comparison of oral ibuprofen and intravenous indomethacin for closure of patent ductus arteriosus in preterm infants.
Chotigeat U; Jirapapa K; Layangkool T
J Med Assoc Thai; 2003 Aug; 86 Suppl 3():S563-9. PubMed ID: 14700149
[TBL] [Abstract][Full Text] [Related]
6. The use of dopamine for the prevention of the renal side effects of indomethacin in premature infants with patent ductus arteriosus.
Seri I; Tulassay T; Kiszel J; Csömör S
Int J Pediatr Nephrol; 1984 Dec; 5(4):209-14. PubMed ID: 6397454
[TBL] [Abstract][Full Text] [Related]
7. Renal impairment associated with indomethacin treatment for patent ductus arteriosus in extremely preterm neonates--is postnatal age at start of treatment important?
Srinivasjois RM; Nathan EA; Doherty DA; Patole SK
J Matern Fetal Neonatal Med; 2006 Dec; 19(12):793-9. PubMed ID: 17190690
[TBL] [Abstract][Full Text] [Related]
8. Dopamine versus epinephrine for cardiovascular support in low birth weight infants: analysis of systemic effects and neonatal clinical outcomes.
Valverde E; Pellicer A; Madero R; Elorza D; Quero J; Cabañas F
Pediatrics; 2006 Jun; 117(6):e1213-22. PubMed ID: 16717120
[TBL] [Abstract][Full Text] [Related]
9. Effect of furosemide on ductal closure and renal function in indomethacin-treated preterm infants during the early neonatal period.
Lee BS; Byun SY; Chung ML; Chang JY; Kim HY; Kim EA; Kim KS; Pi SY
Neonatology; 2010; 98(2):191-9. PubMed ID: 20234144
[TBL] [Abstract][Full Text] [Related]
10. Comparison of oral ibuprofen and indomethacin therapy for patent ductus arteriosus in preterm infants.
Fakhraee SH; Badiee Z; Mojtahedzadeh S; Kazemian M; Kelishadi R
Zhongguo Dang Dai Er Ke Za Zhi; 2007 Oct; 9(5):399-403. PubMed ID: 17937843
[TBL] [Abstract][Full Text] [Related]
11. [Renal effects of prolonged indomethacin therapy in premature infants].
Gouyon JB; Chouchane M; Françoise M
Arch Pediatr; 1994 Oct; 1(10):894-7. PubMed ID: 7842069
[TBL] [Abstract][Full Text] [Related]
12. Indomethacin treatment for symptomatic patent ductus arteriosus: a double-blind control study.
Yanagi RM; Wilson A; Newfeld EA; Aziz KU; Hunt CE
Pediatrics; 1981 May; 67(5):647-52. PubMed ID: 7019841
[TBL] [Abstract][Full Text] [Related]
13. Consequences of delayed surgical closure of patent ductus arteriosus in very premature infants.
Jaillard S; Larrue B; Rakza T; Magnenant E; Warembourg H; Storme L
Ann Thorac Surg; 2006 Jan; 81(1):231-4. PubMed ID: 16368371
[TBL] [Abstract][Full Text] [Related]
14. Predictors of ductal closure and intestinal complications in very low birth weight infants treated with indomethacin.
Madan J; Fiascone J; Balasubramanian V; Griffith J; Hagadorn JI
Neonatology; 2008; 94(1):45-51. PubMed ID: 18196930
[TBL] [Abstract][Full Text] [Related]
15. Indomethacin responsiveness of patent ductus arteriosus and renal abnormalities in preterm infants treated with indomethacin.
Itabashi K; Ohno T; Nishida H
J Pediatr; 2003 Aug; 143(2):203-7. PubMed ID: 12970633
[TBL] [Abstract][Full Text] [Related]
16. Continuous indomethacin infusion may be less effective than bolus infusions for ductal closure in very low birth weight infants.
de Vries NK; Jagroep FK; Jaarsma AS; Elzenga NJ; Bos AF
Am J Perinatol; 2005 Feb; 22(2):71-5. PubMed ID: 15731984
[TBL] [Abstract][Full Text] [Related]
17. Oral ibuprofen in early curative closure of patent ductus arteriosus in very premature infants.
Cherif A; Jabnoun S; Khrouf N
Am J Perinatol; 2007 Jun; 24(6):339-45. PubMed ID: 17564958
[TBL] [Abstract][Full Text] [Related]
18. Early versus late indomethacin treatment for patent ductus arteriosus in premature infants with respiratory distress syndrome.
Van Overmeire B; Van de Broek H; Van Laer P; Weyler J; Vanhaesebrouck P
J Pediatr; 2001 Feb; 138(2):205-11. PubMed ID: 11174617
[TBL] [Abstract][Full Text] [Related]
19. Effectiveness and side effects of an escalating, stepwise approach to indomethacin treatment for symptomatic patent ductus arteriosus in premature infants below 33 weeks of gestation.
Sperandio M; Beedgen B; Feneberg R; Huppertz C; Brüssau J; Pöschl J; Linderkamp O
Pediatrics; 2005 Dec; 116(6):1361-6. PubMed ID: 16322159
[TBL] [Abstract][Full Text] [Related]
20. Necrotizing enterocolitis and gastrointestinal complications after indomethacin therapy and surgical ligation in premature infants with patent ductus arteriosus.
O'Donovan DJ; Baetiong A; Adams K; Chen A; Smith EO; Adams JM; Weisman LE
J Perinatol; 2003 Jun; 23(4):286-90. PubMed ID: 12774134
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
